The present invention provides compounds, compositions thereof, and methods of using the same.
-
Paragraph 0013; 0016-0017
(2021/08/13)
Design of pyrazolo-pyrimidines as 11β-HSD1 inhibitors through optimisation of molecular electrostatic potential
The inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a potentially attractive mechanism for the treatment of obesity and other elements of the metabolic syndrome. A series of pyrazolo-pyrimidine inhibitors of this enzyme were identified from directed library synthesis. Knowledge of how these compounds bind to the enzyme and the key hydrogen-bonding interactions was used to design further compounds. The hydrogen-bond acceptor strength was calculated from the molecular electrostatic potential using quantum mechanical theory. Compounds were designed to modulate the acceptor strength, thus optimising the potency and other drug-like properties. Compounds with enhanced CNS penetration were designed through further modification of the electrostatic potential and the hydrogen-bond properties.
Robb, Graeme R.,Boyd, Scott,Davies, Christopher D.,Dossetter, Alexander G.,Goldberg, Frederick W.,Kemmitt, Paul D.,Scott, James S.,Swales, John G.
supporting information
p. 926 - 934
(2015/05/27)
PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
Compounds of the formula I or II: wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
-
Page/Page column 68
(2012/02/01)
More Articles about upstream products of 1016505-59-1